| A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) (NCT01206582) | Mayo Clinic | 2010-05-01 |
| Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients (NCT01117376) | Shiraz University of Medical Sciences | 2010-05-01 |
| The Use of Domperidone for Gastroparesis (NCT01378884) | Allegiance Health | 2010-03-01 |
| Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers (NCT01074710) | Otsuka Pharmaceutical Co., Ltd. | 2010-02-01 |
| Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers (NCT01329211) | University of Florida | 2010-01-01 |
| Temporary Gastric Electrical Stimulation for Gastroparesis (NCT01054794) | University of Calgary | 2009-12-01 |
| GSK962040 Drug-drug Interaction Study With Ketoconazole (NCT01039974) | GlaxoSmithKline | 2009-09-18 |
| The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis (NCT00861809) | GlaxoSmithKline | 2009-06-01 |
| Medico-economic Evaluation of ENTERRA Therapy (NCT00903799) | University Hospital, Rouen | 2009-06-01 |
| Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus (NCT00889486) | Tranzyme, Inc. | 2009-04-01 |
| Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis (NCT00845858) | Evoke Pharma | 2009-04-01 |
| Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis (NCT01323582) | University of Florida | 2009-02-01 |
| Domperidone in Refractory Gastroparesis (NCT00760461) | Yale University | 2008-10-01 |
| Domperidone for Refractory Gastrointestinal Disorders (NCT00777439) | Arnold, George, M.D. | 2008-10-01 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. (NCT00733551) | GlaxoSmithKline | 2008-09-23 |
| Domperidone for Relief of Gastrointestinal Disorders (NCT00761254) | Carle Physician Group | 2008-08-01 |
| Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis (NCT00612014) | Tranzyme, Inc. | 2007-10-01 |
| A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 (NCT00562848) | GlaxoSmithKline | 2007-09-10 |
| Effects of Sitagliptin on Gastric Emptying in Healthy Subjects (NCT00501657) | Royal Adelaide Hospital | 2007-07-01 |
| A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old (NCT00682877) | The SmartPill Corporation | 2007-07-01 |
| Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis (NCT00492622) | University of Louisville | 2007-06-01 |
| Domperidone for Gastroparesis in Solid Organ Transplantation (NCT00552422) | David J. Lederer, M.D. | 2007-03-01 |
| Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis (NCT00390975) | Novartis | 2007-01-01 |
| Gastroparesis Registry (NCT00398801) | Johns Hopkins Bloomberg School of Public Health | 2006-12-01 |
| Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis (NCT00639808) | Tranzyme, Inc. | 2006-08-01 |
| Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis (NCT00432835) | University of Mississippi Medical Center | 2005-08-01 |
| Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia (NCT00370084) | Forest Laboratories | 2005-03-01 |
| A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time (NCT00128284) | The SmartPill Corporation | 2005-02-01 |
| Enterra Therapy Gastric Stimulation System (NCT00556166) | Columbia University | 2004-10-01 |
| Placebo Controlled Trial of Botulinum Toxin for Gastroparesis (NCT00372970) | Temple University | 2003-07-01 |
| An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus (NCT01286090) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-07-01 |
| An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options (NCT01281540) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-05-01 |
| Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying (NCT00050609) | Eli Lilly and Company | 2003-02-01 |
| Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis) (NCT00157755) | MedtronicNeuro | 2002-06-01 |
| Limited Access Protocol for the Use of Oral Cisapride (NCT02524496) | Yale University | 2001-03-01 |
| Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis (NCT04474990) | Vanda Pharmaceuticals | |
| Domperidone for Chronic Nausea and Vomiting (NCT02757534) | Yehudith Assouline-Dayan | |
| Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis (NCT00050882) | Chugai Pharma USA | |
| Treatment Use of Domperidone for Gastroparesis (NCT02227927) | Scott Gabbard, MD | |
| Use of Domperidone for Treatment of Upper Gastrointestinal Disorders (NCT03128398) | Palo Alto Medical Foundation | |
| The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms (NCT03810287) | Yale University | |
| Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders (NCT02567175) | Prasanna K Kapavarapu | |
| Effect of Electroacupuncture in Diabetic Patients With Gastroparesis (NCT00227383) | China Medical University Hospital | |
| Domperidone Expanded Access Treatment Program (NCT04996134) | Wake Forest University Health Sciences | |